Expression of IFITM1 in chronic myeloid leukemia patients

Creative Commons License

AKYERLİ BOYLU C., BEKSAÇ M., Holko M., Frevel M., Dalva K., ÖZBEK U., ...Daha Fazla

LEUKEMIA RESEARCH, cilt.29, sa.3, ss.283-286, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 3
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.leukres.2004.07.007
  • Dergi Adı: LEUKEMIA RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.283-286
  • Anahtar Kelimeler: chronic myeloid leukemia, IFITM1, RT-PCR, gene expression, GENE-EXPRESSION, MEMBRANE-PROTEIN, ALPHA, MICROARRAY, BIOLOGY, PCR
  • Ankara Üniversitesi Adresli: Evet

Özet

We investigated the peripheral blood gene expression profile of interferon induced transmembrane protein 1 (IFITM1) in sixty chronic myeloid leukemia (CML) patients classified according to new prognostic score (NPS). IFITM1 is a component of a multimeric complex involved in the trunsduction of antiproliferative and cell adhesion signals. Expression level of IFITM1 was found significantly different between the high- and low-risk groups (P = 9.7976 x 10(-11)) by real-time reverse transcription polymerase chain reaction (RT-PCR). Higher IFITM1 expression correlated with improved survival (P = 0.01). These results indicate that IFITM1 expression profiling could be used for molecular classification of CML, which may also predict survival. (C) 2004 Elsevier Ltd. All rights reserved.